Lacey, WA − Unigen Pharmaceuticals, Inc., a leading natural products R&D company and proprietary rights supplier, and the University of Prince Edward Island (UPEI), have announced a partnership, which is the first step in an exciting process of collecting marine organisms from the Atlantic Ocean, with an eye to screening the samples for creating therapeutic and commercial products.
Lacey, WA – Researchers utilizing one of the world’s largest ethnomedicinal plant libraries recently developed two highly potent flavonoid formulas proven to convey topical anti-inflammatory effects. The botanicals, a catechin derived from the catechu tree and baicalin extracted from Chinese skullcap, were combined in two different formula ratios and then evaluated for anti-inflammatory and antioxidant effects.
Lacey, WA − Unigen Pharmaceuticals, Inc., a leading research and development company of proprietary, biologically-active, plant-derived ingredients has filed suit in US District Court in Seattle, alleging that Target Corporation has violated patents that Unigen holds on products containing the ingredients scutellaria and acacia catechu that it produces on an exclusive basis for licensees in the food, drug and mass market.
Lacey, WA − Unigen Pharmaceuticals, Inc., a leading research and development company of proprietary, biologically-active, plant-derived ingredients announced it had settled a case, brought in US District Court in Seattle, alleging Leiner Health Products and Safeway had violated patents Unigen holds on products containing the ingredients scutellaria and acacia catechu, that it produces on an exclusive basis in the food, drug and mass market for one of its licensees.
Phytologix® is a proprietary platform for the development of novel cosmetic agents from documented medicinal plants. Using multi-parallel extraction and purification systems, a library that contains 8,000 plant extracts and 200,000 fractions has been generated. The library has been screened in high-throughput format against targets related to skin pigmentation, inflammation, oxygen free-radical clearance capacity and anti-microbial properties.
Silver Medal: Unigen Pharmaceuticals
LACEY, WA – With nearly a decade of experience in researching and developing novel proprietary botanical ingredients, leading industry supplier UNIGEN USA has now announced the creation of a new Organic Synthesis Department at its Washington State headquarters. In response to concerns about long-term environmental impact, the new department will create synthetic versions of certain natural compounds. Consequently, Unigen will be able to offer to its customers the positive effects of raw ingredients whose source material is in limited supply.
Lacey, WA − Unigen Pharmaceuticals, Inc., a leading research and development company of proprietary, biologically active plant-derived ingredients recently highlighted novel cosmetic ingredients at the Society of Cosmetic Chemists Technology Showcase in New York City.
Lacey, WA − Unigen Pharmaceuticals, Inc. − part of the ECONET global group of health and natural product companies with operations in the United States, South Korea, Russia, China and Mexico − recently hosted its 9th Annual Science Summit at its US corporate headquarters in Lacey, Washington.
Lacey, WA − Unigen Pharmaceuticals, Inc., a leading research and development company of proprietary, biologically active plant-derived ingredients, announced the appointment of Douglas Lynch as Vice President Sales and Marketing.
Lacey, WA − A cutting-edge environmental development for ECONET, Inc. that is a first for this area of Washington State and on the cutting edge of corporate campus development world wide, is set to break ground in Lacey, Washington in early 2007. ECONET, Inc., parent company for Unigen Pharmaceuticals, Inc., Aloecorp, Inc. and Univera LifeSciences, Inc., is part of a global family of health and natural product companies with operations in the United States, South Korea, Russia, China and Mexico.
Lacey, WA − Unigen Pharmaceuticals, Inc., leading research and development company of proprietary, biologically active plant-derived ingredients, named company veteran Regan D. Miles as Chief Executive Officer. Miles, who joined Unigen in April, 2002 was named President and Chief Operating Officer in August, 2005.
Lacey, WA − Unigen Pharmaceuticals, Inc., a leading research and development company of proprietary, biologically active plant-derived ingredients has received notification of approval for free-b-ring flavonoid USA patent (Patent Number US 7,108,868 B2) supporting their novel Univestin joint health ingredient.
Lacey, WA − Unigen Pharmaceuticals, Inc., a leading research and development facility and supplier of proprietary, biologically active plant-derived ingredients to the natural products and pharmaceutical industries, has announced the launch of Soliprin™, a science-based all-natural skin care product.